Rare and emerging subtypes of leukemia can be incredibly challenging to diagnose and even more challenging to treat. At the NCCN 2019 Annual Congress: Hematologic Malignancies, a panel of experts, moderated by Andrew D. Zelenetz, MD, PhD, were presented with particularly challenging cases in these malignancies and asked to discuss best approaches to treatment.
Pemmaraju N, Lane AA, Sweet KL, . Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med 2019;380:1628–1637.
Stock W, Luger SW, Advani AS, . A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood 2016;133:1548–1559.
Jain N, Roberts KG, Jabbour E, . Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 2017;129:572–581.